Imprint

Address: CEVEC Pharmaceuticals GmbH
Gottfried-Hagen Str. 62
D-51105 Köln
Germany
 
Phone: +49 (0)2 21- 46 02 08 00
Fax: +49 (0)2 21- 46 02 08 01
E-Mail: lichtenberger@cevec-pharmaceuticals.com
Internet: www.cevec-pharmaceuticals.com
Represented by: Dr. Rainer Lichtenberger
Register Court: Amtsgericht Köln
Trade Register Number: HRB 34497
VAT ID Number: DE 813198388

The contents of this website are only intended for general information about CEVEC and its CAP-Technology only and have been carefully reviewed and compiled. CEVEC makes no claim or warranties as to the accuracy or completeness or the up-to-dateness of the contents of this website and can assume no liability arising there from. CEVEC reserves the right to amend, complete or to delete the contents of this website in whole or in part at any time and without prior written notice. CEVEC has no obligation to up-date the contents of this website. CEVEC accepts no responsibility for the contents of external websites accessed via links.

 
   CompanyTechnologyManagementScientific BoardPartnershipsInvestor RelationsNewsCareersContactImprint Using CEVEC's proprietary technology, primary human amniocytes have been immortalized by adenoviral genetic E1/pIX functions and selected for highly efficient CAP (CEVEC's Amniocyte Production) Cell Lines. CAP (CEVEC's Amniocyte Production) Cell Lines contain adenovirus type 5 nucleotide sequence 505-4079 including the E1 genes and the entire pIX sequence.